Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Conmed (CNMD) Other Operating Expenses (2022 - 2025)

Conmed's Other Operating Expenses history spans 8 years, with the latest figure at -$327.6 million for Q4 2025.

  • For Q4 2025, Other Operating Expenses fell 27.86% year-over-year to -$327.6 million; the TTM value through Dec 2025 reached -$108.4 million, up 34.18%, while the annual FY2023 figure was $391.8 million, 9.46% up from the prior year.
  • Other Operating Expenses reached -$327.6 million in Q4 2025 per CNMD's latest filing, down from $103.0 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $391.8 million in Q4 2023 to a low of -$327.6 million in Q4 2025.
  • Average Other Operating Expenses over 4 years is $68.1 million, with a median of $103.0 million recorded in 2025.
  • Peak YoY movement for Other Operating Expenses: tumbled 165.4% in 2024, then grew 26.96% in 2025.
  • A 4-year view of Other Operating Expenses shows it stood at $357.9 million in 2022, then rose by 9.46% to $391.8 million in 2023, then crashed by 165.4% to -$256.2 million in 2024, then decreased by 27.86% to -$327.6 million in 2025.
  • Per Business Quant, the three most recent readings for CNMD's Other Operating Expenses are -$327.6 million (Q4 2025), $103.0 million (Q2 2025), and $116.2 million (Q1 2025).